Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Experimental Therapeutics

Peptide Inhibitors Targeting the Neisseria gonorrhoeae Pivotal Anaerobic Respiration Factor AniA

Aleksandra E. Sikora, Robert H. Mills, Jacob V. Weber, Adel Hamza, Bryan W. Passow, Andrew Romaine, Zachary A. Williamson, Robert W. Reed, Ryszard A. Zielke, Konstantin V. Korotkov
Aleksandra E. Sikora
aDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aleksandra E. Sikora
Robert H. Mills
aDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob V. Weber
aDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adel Hamza
bDepartment of Molecular & Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan W. Passow
aDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Romaine
aDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zachary A. Williamson
bDepartment of Molecular & Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert W. Reed
bDepartment of Molecular & Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryszard A. Zielke
aDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantin V. Korotkov
bDepartment of Molecular & Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.00186-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Structural and functional analysis of AniA. (A) Schematic illustration of AniA function in the Neisseria gonorrhoeae denitrification pathway. A two-step denitrification pathway in N. gonorrhoeae is comprised of AniA (NGO1276), which reduces nitrite to nitric oxide, and NorB, which subsequently reduces nitric oxide to nitrous oxide. (B, C) The crystal structure of the AniA trimer shown in ribbon representation with three subunits colored in green, magenta, and cyan. Side (B) and top (C) views are shown. Each monomer contains two Cu2+ ions, shown as gold spheres. (D) Diagram of native AniA and the recombinant variant proteins sAniA and mutated AniA D137A H280A. Gray, signal peptide (SP), amino acids 1 to 20; green, N-terminal cupredoxin domain, amino acids 102 to 198; yellow, C-terminal cupredoxin domain, amino acids 205 to 348; red, the C-terminal 6× His tag. The active-site residues aspartate (D137) and histidine (H280) are also shown. (E) Effect of genetic inactivation of aniA and point mutations D137A and H280A on N. gonorrhoeae survival under anoxia. Wild-type (wt) strain FA1090, the isogenic knockout ΔaniA strain, the complemented ΔaniA/Plac::aniA strain, and the ΔaniA strain carrying a mutated version of AniA, ΔaniA/Plac::aniA D137A H280A, were grown in broth to an OD600 of 0.2, serially diluted, and spotted onto solid medium supplemented with nitrite and 0.1 mM IPTG. Growth was examined after 22 and 48 h of incubation under aerobic and anaerobic conditions, respectively. (F) Measurements of the nitrite reductase activity of AniA obtained using a fluorometric 2,3-diaminophtalene (DAN) assay. The consumption of nitrite was examined at 37°C under anaerobic conditions in a solution containing sodium nitrite, methyl viologen, sodium dithionate, Tris-HCl, pH 7.0, and either decreasing concentrations of sAniA (in micromolar, as indicated) or AniA D137A H280A (1 μM). The data show the mean reaction rates with the associated SEMs (n = 10).

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    AniA is expressed in a diverse panel of N. gonorrhoeae isolates. N. gonorrhoeae wild-type strain FA1090, the isogenic ΔaniA/Plac::aniA strain, and the ΔaniA/Plac::aniA D137A H280A strain, as well as 36 additional strains of N. gonorrhoeae, as indicated above the immunoblots, were grown concurrently on solid medium for 20 h in 5% CO2 at 37°C. The ΔaniA/Plac::aniA and ΔaniA/Plac::aniA D137A H280A strains were grown on solid medium supplemented with IPTG. Samples containing the whole-cell lysates were matched by equivalent OD600 units, resolved in a 4 to 20% Tris-glycine gel, and transferred onto nitrocellulose. The immunoblotting was performed using polyclonal rabbit antiserum against sAniA.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Targeting AniA using a phage display approach. (A) The recombinant version of AniA, sAniA, was purified to homogeneity and used in an affinity capture method as the bait during three panning experiments with two phage display libraries expressing either randomized linear 12-mer peptides (Ph.D.-12) or randomized 7-mer peptides flanked by a pair of cysteine residues (Ph.D.-C7C). As a first step in every round of the panning experiment, both peptide libraries were precleared against Ni-NTA magnetic chitin resin to remove nonspecifically binding peptides. The supernatants from this step were then added to 200 μg of sAniA bound to the resin. After incubation with the protein, unbound phages were washed away using TBST, with an increasing stringency of the washing being used in consecutive rounds. The elutions were performed with glycine-HCl (pH 2.2). (B) Deduced peptide sequences of the 7-mer and 12-mer peptides obtained by sequencing of the DNA of 24 randomly selected phages from each group eluted after the third round of biopanning. These studies revealed 26 unique peptides, with 1 of them, C7-3, being identified multiple times. Synthesized peptides are shown in red. (C) Evaluation of the identified peptides through phage ELISA. Phage clones were purified and tested separately to measure their affinity to sAniA in the phage ELISA. Purified sAniA (2 μM) was coated overnight at 4°C on 96-well flat-bottom plates. After the coating step, unbound sAniA was removed and the wells were thoroughly washed with the storage buffer. The wells were blocked and incubated with 1010 PFU per well from each amplification. After washing, the anti-M13 monoclonal antisera coupled to horseradish peroxidase were added. Unbound antisera were removed by excessive washing, and enzymatic activity was exerted by the addition of Turbo TMB-ELISA substrate. The absorbance at 450 nm was measured. Readings were compared to those of wells which underwent an identical treatment but lacked sAniA (control) and to the signal from a wild-type phage, M13KE (1010 PFU), that did not display peptides (wild type). The means and SEMs from seven independent experiments are shown. Clones 3* and 5 (in red) were identified multiple times. *, P < 0.05.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Normal mode analysis (NMA) of the conformational transition of the homotrimer AniA structure. The motion of the combined four lowest normal modes of vibrations described the opening and closing states of cupredoxin domain II (Cu2+ catalytic active site) of the AniA structure. Thus, NMA revealed the tendency of the protein to move in a certain direction, even though this movement was not fully explored during the MD simulations. The view on the top of the catalytic active site of the AniA structure shows that the flexibility of the protein is well oriented and can dramatically change the accessible area of the catalytic metal ion Cu2+ and its potential interaction with a ligand (NO2 or peptide). The open state of the homotrimer AniA structure was used to identify several binding pockets. These conformations essentially depended on the sequence of the residue composing the peptide. Afterward, the initial conformation of the peptide (which is in a stable conformation in the solvent) was slightly perturbed during the docking procedure due to the interactions with the receptor.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    Stick view of the interaction of the peptide 12-5 Tyr side chain in the catalytic active site of AniA homotrimer. The Tyr side chain of the peptide fits in the cavity and established strong van der Waals contact with the hydrophobic residues of the cavity, while the hydroxyl group of the Tyr formed an H bond with the Asp137 residue.

  • FIG 6
    • Open in new tab
    • Download powerpoint
    FIG 6

    Binding studies. (A, B) Binding mode of C7-3 (A) and 12-5 (B) in the Cu2+ active site of the AniA homotrimer. Peptides C7-3 (A) and 12-5 (B) bound in the AniA pocket with distinct conformations. These conformations essentially depended on the sequence of the residues composing the peptide. Afterward, the initial conformation of the peptide (which is in a stable conformation in the solvent) was slightly perturbed during the docking procedure due to the interactions with the receptor. (C) Inhibition of nitrite reductase activity of sAniA. Nitrite reductase inhibition plot of sAniA with synthetic peptides C7-3 and 12-5 and mutated variants of C7-3 (C7-3m1, C7-3m2, C7-3P, and C7-3A). sAniA was preincubated with various concentrations (0 to 100 μM) of synthetic peptides for 1 h at room temperature following measurement of nitrite reductase activity with DAN. Percent inhibition was calculated using the formula 100 · {1 − [(x − y)/(z − y)]}, where x, y, and z are the concentrations of nitrite in samples containing sAniA incubated with synthetic peptides, AniA D137A H280A, and sAniA, respectively. (D) Inhibition of the nitrite reductase activity of intact N. gonorrhoeae cells. Inhibition of nitrite reductase AniA was assessed using intact gonococci. Bacteria were preincubated with different concentrations of synthetic peptides (0, 0.6, 0.3, and 0.15 mM) for 1 h, followed by measurement of nitrite reductase activity using DAN. Percent inhibition was calculated using the formula 100 · {1 − [(x − y)/(z − y)]}, where x, y, and z are the concentrations of nitrite in samples containing FA1090 ΔaniA/Plac::aniA incubated with synthetic peptides, ΔaniA/Plac::aniA D137A H280A, and ΔaniA/Plac::aniA, respectively. Statistically significant P values are reported. (E) Kinetic analyses of the interaction between AniA and C7-3. The binding affinity between AniA and the C7-3 peptide was measured using biolayer interferometry. The biotinylated C7-3 peptide was immobilized on a streptavidin-coated sensor and incubated with increasing concentrations of recombinant AniA (50 to 1,000 nM). Experiments were repeated on three separate occasions, and the dissociation constants were calculated by globally fitting the curves with 2:1 binding kinetics. The KD determined for C7-3 was 775 ± 88.5 nM (average ± SEM from three independent experiments).

Tables

  • Figures
  • Additional Files
  • TABLE 1

    Data collection and refinement statistics

    ParameteraValue(s) for AniA with PDB accession no.b:
    5TB75UE6
    Data collection statistics
        Wavelength (Å)1.00001.0000
        Space groupP212121I4122
        Unit cell dimensions
            a, b, c (Å)76.23, 129.10, 136.72177.34, 177.34, 449.46
            α, β, γ (°)90, 90, 9090, 90, 90
        Resolution (Å)66.58–1.90 (1.95–1.90)83.68–2.35 (2.41–2.35)
        Rsym0.090 (1.038)0.179 (1.050)
        CC1/299.8 (67.7)99.0 (75.4)
        I/σI11.7 (1.9)5.8 (1.8)
        Completeness (%)99.2 (100)84.8 (83.3)
        Multiplicity6.2 (6.3)4.2 (3.9)
    Refinement statistics
        Resolution (Å)66.58–1.9083.68–2.35
        No. of reflections (total/free)105,946/10,240125,511/11,871
        Rwork/Rfree0.155/0.1790.236/0.259
        No. of atoms
            Protein7,15621,242
            Ligand/ion2127
            Water486984
        B factors
            Protein34.137.2
            Ligand/ion53.736.5
            Water41.932.2
            All atoms34.636.1
        Wilson B37.431.7
        RMSD
            Bond lengths (Å)0.0100.003
            Bond angles (°)1.0060.638
        Ramachandran distributionc (%)
            Favored98.798.2
            Outliers00
        MolProbity scored0.710.79
    • ↵a CC1/2, correlation coefficient, as defined in the work of Karplus and Diederichs (101) and calculated by XSCALE (102); I, intensity of a reflection; RMSD, root mean square deviation.

    • ↵b Values in parentheses are for the highest-resolution shell.

    • ↵c Calculated using the MolProbity server (http://molprobity.biochem.duke.edu ) (73).

    • ↵d MolProbity score combines the clash score, rotamer, and Ramachandran evaluations into a single score, normalized to be on the same scale as the X-ray resolution (73).

  • TABLE 2

    In silico analysis of ΔΔG of C7-3 and variants simulated by MD interacting in the Cu2+ cavity of the AniA homotrimera

    PeptidebΔΔG (kcal/mol)
    CNYCRLNLW0.0
    CNYSRLNLW−0.5
    CSYCRLNLW−0.8
    KHYYGGDTTTLW0.0
    KHYYGNDTTTLW−0.6
    KHYYGSDTTTLW−0.9
    KHYYGGDTTSLW−0.8
    KHYYGGETTTLW−0.6
    • ↵a To validate the peptide binding prediction and highlight the key residues of the peptides involved in the interactions with the receptor, we mutated in silico some specific residues and computed the relative binding free energy of the mutants simulated by MD, where ΔΔG = ΔG for the mutant − ΔG for the wild type. The peptides CNYCRLNLW and KHYYGGDTTTLW were wild types and were assigned ΔΔG values of 0.0 kcal/mol.

    • ↵b Boldface amino acids are those that were mutated in silico.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    • Supplemental file 1 -

      Supplemental Figures S1 to S3

      PDF, 211K

PreviousNext
Back to top
Download PDF
Citation Tools
Peptide Inhibitors Targeting the Neisseria gonorrhoeae Pivotal Anaerobic Respiration Factor AniA
Aleksandra E. Sikora, Robert H. Mills, Jacob V. Weber, Adel Hamza, Bryan W. Passow, Andrew Romaine, Zachary A. Williamson, Robert W. Reed, Ryszard A. Zielke, Konstantin V. Korotkov
Antimicrobial Agents and Chemotherapy Jul 2017, 61 (8) e00186-17; DOI: 10.1128/AAC.00186-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Peptide Inhibitors Targeting the Neisseria gonorrhoeae Pivotal Anaerobic Respiration Factor AniA
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Peptide Inhibitors Targeting the Neisseria gonorrhoeae Pivotal Anaerobic Respiration Factor AniA
Aleksandra E. Sikora, Robert H. Mills, Jacob V. Weber, Adel Hamza, Bryan W. Passow, Andrew Romaine, Zachary A. Williamson, Robert W. Reed, Ryszard A. Zielke, Konstantin V. Korotkov
Antimicrobial Agents and Chemotherapy Jul 2017, 61 (8) e00186-17; DOI: 10.1128/AAC.00186-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacterial Outer Membrane Proteins
gonorrhea
Neisseria gonorrhoeae
oxygen
peptides
Neisseria gonorrhoeae
anaerobic respiration
AniA
nitrite reductase
phage display
peptide inhibitors
crystal structure
docking studies
biolayer interferometry

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596